"While a PBM’s
book-of-business results can be informative, the biggest determinant of trend
outcomes for a plan sponsor is the management approach that they choose to
implement. PBMs provide a framework for managing cost, but plan sponsors are
ultimately at the helm."
— Josh Golden,
area senior vice president for Arthur J. Gallagher & Co.’s Solid Benefit
Guidance, spoke with AIS’s RADAR
on Drug Benefits about Prime Therapeutics’ positive financial
outcomes from implementing its new tightly-managed ‘NetResults’ formulary.
No comments:
Post a Comment